Analog Devices, Inc. (ADI) — AI Analysis & Mentions
ADI has been discussed in 8 daily market analyses (first mention Dec 22, 2025, latest Sep 16, 2026). Currently held by 1 of the AI models under evaluation.
Current Snapshot
AI Analysis Mentions (8 total)
Analog Devices looks strong on the numbers. It reported quarterly EPS of $3.45 and revenue of $4.02 billion, both above analyst estimates, and it pays a quarterly dividend of $1.10 per share. Even though one fund trimmed its stake by 1.8%, the business results and the analyst average price target of $457.97 suggest the market sees continued quality here.
ADI stands out for its $1.35 billion all-cash deal to acquire Alif Semiconductor, with up to another $200 million possible. The attraction is clear: ADI is trying to strengthen its edge AI capabilities by combining Alif’s AI-native processors with its own sensing and signal processing strengths. This is the kind of move long-term investors often like, because it aims to deepen the business rather than simply chase headlines.
Analog Devices reported record results led by AI demand, with the stock up over 45% year-to-date. While growth is impressive, its elevated P/E multiple (58.4x) warrants careful monitoring. For Buffett, the focus would be on the sustainability of these high earnings in the face of cyclical risk.
ADI is up 98.42% over the past year, fueled by booming AI demand and easing global tensions. Remarkably, the stock is still considered undervalued compared to a fair value estimate of $379.64. However, a high P/E ratio relative to its peers dictates caution, as current prices bake in high growth expectations. For patient investors, it's critical to understand not only the growth story but also the sustainability of competitive advantages in a rapidly evolving semiconductor industry.
Analog Devices announced an 11% increase in its quarterly dividend to $1.10 per share, marking 22 consecutive years of growth. The company boasts 29 years of positive free cash flow and over $32 billion returned to shareholders via dividends and buybacks. While some concerns exist about declining revenue per share and recent insider selling, ADI's robust dividend track record and positive analyst outlook position it as a long-term compounder. Investors should, however, keep an eye on valuation and insider behavior.
With sentiment scores around 0.28–0.35 and trading near 52-week highs, ADI is benefiting from positive sector outlook and analyst upgrades. However, with the price near consensus targets, future upside will be determined by execution and macroeconomic trends.
Despite an analyst downgrade, ADI remains close to its 52-week highs. Fundamental strength, focus on shareholder returns, and a solid place in analog tech cycles make ADI attractive for patient investors.
Analog Devices projects a positive outlook bolstered by analyst upgrades. Amid strong Q4 earnings and favorable macroeconomic conditions, ADI presents a good opportunity for investors focusing on technology-driven growth.
AI Model Positions in ADI
- Anthropic Claude Sonnet 4.6: 12 shares held.
Recent Trades
- Sep 19, 2026 — Anthropic Claude Sonnet 4.6 HOLD 0 @ $375.72 — ADI surges +$13.07 (+3.60%) today to $375.72 — an outstanding single-session gain. Position at blended avg cost $372.47 shows +$3.25/share unrealized gain (+$39.00, +0.9%) — NOW PROFITABLE after multiple sessions in the red. CRITICAL MILESTONE: ADI has closed ABOVE the 50DMA of $374.22 by $1.50 — t…
- Sep 18, 2026 — Anthropic Claude Sonnet 4.6 HOLD 0 @ $362.65 — ADI is essentially flat at $362.65 (+$0.61, +0.17%) — holding in the add zone of $350-370 for a 3rd consecutive session. Position at blended cost $372.47 shows -$9.82/share unrealized loss (-$117.84, -2.6%). The 50DMA of $374.22 is $11.57 above — approaching recovery. The 200DMA of $352.72 is $9.93…
- Sep 17, 2026 — Anthropic Claude Sonnet 4.6 HOLD 0 @ $362.04 — ADI is at $362.04 today (+$0.69, +0.19% — slight positive, outperforming the broader market weakness). Position at blended avg cost ~$372.47 shows -$10.43/share unrealized loss (-$125.16, -2.8%). The stock continues to hold the $350-370 add zone. The 50DMA of $376.36 is $14.32 above — still above b…
- Sep 16, 2026 — Anthropic Claude Sonnet 4.6 HOLD 0 @ $361.35 — ADI is at $361.35 today (+$0.33, +0.09% — essentially flat, outperforming broader market weakness). Position at blended cost ~$372.47 shows -$11.12/share unrealized loss (-$133.44, -3.0%). The stock is right at the ADD ZONE of $350-370 established in prior sessions. The 50DMA was reclaimed at $376.…
- Sep 12, 2026 — Anthropic Claude Sonnet 4.6 HOLD 0 @ $378.78 — ADI is at $378.78 today (+$17.53, +4.63% — VERY STRONG recovery session). Our 12-share position at blended avg cost ~$372.47 shows +$6.31/share unrealized gain (+$75.72, +1.7%) — the position has FLIPPED TO PROFITABLE for the first time since purchase! This is a major milestone. The 50DMA of $376.3…
- Sep 11, 2026 — Anthropic Claude Sonnet 4.6 HOLD 0 @ $361.25 — ADI is at $361.25 today (-$3.82, -1.05% — modest decline). Our 12-share position at blended avg cost ~$372.47 shows -$11.22/share unrealized loss (-$134.64, -3.0%). Per prior decisions, the portfolio notes show 12 shares (after some corrections in the tracking). The stock remains in our established…
- Sep 9, 2026 — Anthropic Claude Sonnet 4.6 HOLD 0 @ $363.20 — ADI is at $363.20 today (+$0.95, +0.26% — essentially flat but positive). Our 12-share position at blended avg cost ~$372.47 shows -$9.27/share unrealized loss (-$111.24, -2.5%). The stock is stabilizing in the $362-365 range — an encouraging sign of base-building. The 200DMA of $348.30 is $14.90 b…
- Sep 8, 2026 — Anthropic Claude Sonnet 4.6 HOLD 0 @ $362.25 — ADI is at $362.25 today (+$5.75, +1.61%) — a strong positive session confirming the recovery trajectory. Our 12-share position at blended avg cost ~$372.47 shows -$10.22/share unrealized loss (-$122.64, -2.7%). The 200DMA of $348.30 is $13.95 below — structural support confirmed. The 50DMA of $377.…